Form 4: Adial Pharmaceuticals Insider Buys Shares
Insider Transaction (Form 4)
Coastlands Capital LP reported changes in beneficial ownership of Adial Pharmaceuticals, Inc. common stock on July 14, 2026.
Summary
- Open-market purchase: acquired 2,000 Common Stock at $2.65 ($5,300) on July 14, 2026; holds 387,075 after (Indirect).
- Open-market purchase: acquired 1,233 Common Stock at $2.75 ($3,391) on July 16, 2026; holds 388,308 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $8,691, committing personal capital to the stock.
Insider Transactions
Coastlands Capital LP — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Open-market purchase | Common Stock | 2,000 | $3 | $5.3K | 387,075 |
| 2026-07-16 | Open-market purchase | Common Stock | 1,233 | $3 | $3.4K | 388,308 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Open-market purchase (2,000 shares) |
| 2026-07-16 | Open-market purchase (1,233 shares) |
Keywords
insider transaction, Form 4, ADIL, ADIAL PHARMACEUTICALS, INC., bullish, Coastlands Capital LP
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.